Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Scientific Reports, 2022Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation
Oliveras T., Revuelta-López E., García-García C. et al.
Olink Target 96
Clinical and Translational Medicine, 2022Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
García‐Hidalgo M., González J., Benítez I. et al.
mBio, 2022Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections
Rosendal E., Mihai I., Becker M. et al.
Olink Target 48
Scandinavian Journal of Pain, 2022Association between systemic inflammation and experimental pain sensitivity in subjects with pain and painless neuropathy after traumatic nerve injuries
Miclescu A., Granlund P., Butler S. et al.
Journal of Cardiovascular Translational Research, 2022Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1
Fairhurst-Hunter Z., Walters R., Zink A. et al.
Proteomes, 2022Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer
Mukherjee A., Pednekar C., Kolke S. et al.
PROTEOMICS – Clinical Applications, 2022Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
He B., Huang Z., Huang C. et al.
Molecular Metabolism, 2022Gene-based whole genome sequencing meta-analysis of 250 circulating proteins in three isolated European populations
Gilly A., Klaric L., Park Y. et al.
Biochemical and Biophysical Research Communications, 2022A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates
Sjoqvist S., Otake K.
Cell, 2022Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
Wei T., Chandy M., Nishiga M. et al.
Translational Psychiatry, 2022Metabolomics analysis of post-traumatic stress disorder symptoms in World Trade Center responders
Kuan P., Yang X., Kotov R. et al.
Frontiers in Aging Neuroscience, 2022The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the AppNL–G–F Model of Alzheimer’s Disease
Nieraad H., de Bruin N., Arne O. et al.
Olink Target 96 Mouse
International Journal of Obesity, 2022Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study
Maalmi H., Herder C., Huth C. et al.
Biomedicines, 2022Cerebrospinal Fluid in Classical Trigeminal Neuralgia: An Exploratory Study on Candidate Biomarkers
Svedung Wettervik T., Folkvaljon D., Gordh T. et al.
Research and Practice in Thrombosis and Haemostasis, 2022Proteomics in thrombosis research
Edfors F., Iglesias M., Butler L. et al.
Expert Review of Proteomics, 2022Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications
Dayon L., Cominetti O., Affolter M.
BJS Open, 2022Preoperative biomarkers related to inflammation may identify high-risk anastomoses in colorectal cancer surgery: explorative study
Holmgren K., Jonsson P., Lundin C. et al.
European Stroke Journal, 2022A novel biomarker panel index improves risk stratification after ischemic stroke
Bicvic A., Scherrer N., Schweizer J. et al.
Cell Reports, 2022Systems analysis shows a role of cytophilic antibodies in shaping innate tolerance to malaria
Lautenbach M., Yman V., Silva C. et al.
Scientific Reports, 2022Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90
Heath L., Earls J., Magis A. et al.
3144 publications
Items per page
1761-1780 of 3144 publications